Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Agenus Inc (NQ: AGEN )

1.555 +0.075 (+5.07%)
Streaming Delayed Price Updated: 10:03 AM EDT, Mar 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 519,012
Open 1.490
Bid (Size) 1.550 (72)
Ask (Size) 1.560 (90)
Prev. Close 1.480
Today's Range 1.480 - 1.585
52wk Range 1.250 - 3.370
Shares Outstanding 332,513,275
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Agenus' Investigational Cancer Combo Therapy Shows 33% Durable Responses In Ovarian Cancer
 
Via Benzinga
Agenus’ Botensilimab in Combination with Balstilimab Shows 33% Durable Responses in Ovarian Cancer
From Agenus Inc.
Via Business Wire

Performance

YTD
-35.21%
-35.21%
1 Month
-21.07%
-21.07%
3 Month
-32.97%
-32.97%
6 Month
-23.77%
-23.77%
1 Year
-41.76%
-41.76%

More News

Read More
Why Agenus Stock Is Slumping This Week
Via The Motley Fool
Agenus (AGEN) Q4 2022 Earnings Call Transcript
Via The Motley Fool
Agenus Reports Fourth Quarter and Full Year 2022 Financial Results and Outlines 2023 Objectives
From Agenus Inc.
Via Globe NewsWire
Earnings Preview For Agenus
Via Benzinga
Looking Into Agenus's Return On Capital Employed
Via Benzinga
Why Shares of Agenus Rose 12.5% on Friday
Via The Motley Fool
Illumina, Seagen And Other Big Stocks Moving Higher On Monday
Via Benzinga
Agenus Cancels Conference Call to Discuss the Company’s Minority Cash Holdings at SVB in Light of Government’s SVB Deposit Access Announcement
From Agenus Inc.
Via Globe NewsWire
Agenus Schedules Conference Call to Discuss the Company’s Minority Cash Holdings at SVB
From Agenus Inc.
Via Globe NewsWire
Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2022 Financial Report
From Agenus Inc.
Via Globe NewsWire
Agenus to Present Botensilimab Data in Oral Plenary Session at the Society of Gynecologic Oncology 2023 Annual Meeting on Women’s Cancer
From Agenus Inc.
Via Globe NewsWire
Agenus to Participate in February Investor Conferences
From Agenus Inc.
Via Globe NewsWire
Agenus Presents Clinical Data Demonstrating Durable Responses For Colorectal Cancer Candidate
Via Benzinga
Agenus Presents Clinical Data Demonstrating Durable Responses of Botensilimab/Balstilimab Combination in Metastatic Microsatellite Stable Colorectal Cancer at ASCO GI
From Agenus Inc.
Via Globe NewsWire
Agenus to Participate at B Riley Securities’ 2023 Virtual Oncology Conference
From Agenus Inc.
Via Globe NewsWire
Benzinga's Top Ratings Upgrades, Downgrades For December 22, 2022
Via Benzinga
Agenus to Present Botensilimab Data at Late-Breaking Oral Session at ASCO-GI
From Agenus Inc.
Via Globe NewsWire
7 Hot Stocks to Book Profits In Before 2023
Via InvestorPlace
Agenus Data at CTOS 2022 Highlight Durable Clinical Responses of Botensilimab / Balstilimab Combination in Advanced Sarcoma
From Agenus Inc.
Via Globe NewsWire
Agenus to Participate at 5th Annual Evercore ISI HealthCONx Conference
From Agenus Inc.
Via Globe NewsWire
Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday
Via Benzinga
Miniso Group, Monday.com And Other Big Gainers From Monday
Via Benzinga
Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.